MAPT and Mental deterioration: Given that soluble pTau-181 levels are known to rise prior to significant increases in cortical tau [52], and cortical tau is strongly associated with cognitive decline [59], associations of plasma pTau-181 with cognitive decline may be observed only at a later disease stage or with a longer follow-up period.